Orlistat
規格
96829-58-2CAS番号
639-755-1EC番号
[(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl] (2S)-2-formamido-4-methylpentanoateIUPAC名
C29H53NO5化学式
495.7 g/mol分子量
orlistat; 96829-58-2; Tetrahydrolipstatin; Xenical; Orlipastat; Alli; (-)-Tetrahydrolipstatin; THLP; tetrahydrolipastatin; Ro 18-0647/002; orlistatum; DTXSID8023395; [(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl] (2S)-2-formamido-4-methylpentanoate; Ro-18-0647/002; (2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl (2S)-2-formamido-4-methylpentanoate; 95M8R751W8; NSC-758881; Ro-180647002; Ro-180647-002; CHEBI:94686; DTXCID40820067; L-Leucine, N-formyl-, 1-((3-hexyl-4-oxo-2-oxetanyl)methyl)dodecyl ester, (2S-(2alpha(R*),3beta))-; Beacita; ((2S)-1-((2S,3S)-3-hexyl-4-oxooxetan-2-yl)tridecan-2-yl) (2S)-2-formamido-4-methylpentanoate; (2S)-1-((2S,3S)-3-hexyl-4-oxooxetan-2-yl)tridecan-2-yl (2S)-2-formamido-4-methylpentanoate; RefChem:389166; A08AB01; Ro 18 0647; 639-755-1; Orlipastatum [INN-Latin]; Orlistat (Alli, Xenical); MFCD05662360; N-Formyl-L-leucine (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester; Orlistat (Standard); L-Leucine, N-formyl-, (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester; Ro-18-0647; C29H53NO5; MLS002207022; N-Formyl-L-leucine, ester with (3S,4S)-3-hexyl-4-((2S)-2-hydroxytridecyl)-2-oxetanone; CHEMBL175247; Orlipastatum; SMR000466339; L-Leucine, N-formyl-, (1S)-1-(((2S,3S)-3-hexyl-4-oxo-2-oxetanyl)methyl)dodecyl ester; [(1S)-1-[[(2S,3S)-3-hexyl-4-oxo-oxetan-2-yl]methyl]dodecyl] (2S)-2-formamido-4-methyl-pentanoate; Orlistat Powder; (S)-(S)-1-((2S,3S)-3-Hexyl-4-oxooxetan-2-yl)tridecan-2-yl 2-formamido-4-methylpentanoate; (2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl N-formyl-L-leucinate; Xenical (TN); CAS-96829-58-2; SR-01000759417; Orlistat [USAN:INN:BAN]; UNII-95M8R751W8; HSDB 7556; N-formyl-L-leucine (1S)-1-{[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl}dodecyl ester; NCGC00095128-01; (-)-Tetrahydrolipstatin; Orlistat; Ro 18-0647/002; Tetrahydrolipstatin; Xenical; L-Leucine, N-formyl-, 1-[(3-hexyl-4-oxo-2-oxetanyl)methyl]dodecyl ester, [2S-[2alpha(R*),3beta]]-; KS-1183; ORLISTAT [HSDB]; ORLISTAT [USAN]; ORLISTAT [INN]; ORLISTAT [JAN]; ORLISTAT [MI]; (-)-tetrahydrolipostatin; ORLISTAT [VANDF]; R-212; ORLISTAT [MART.]; ORLISTAT [USP-RS]; ORLISTAT [WHO-DD]; Orlistat (JAN/USP/INN); ORLISTAT [EMA EPAR]; Orlistat, >=98%, solid; SCHEMBL16408; MLS000759448; MLS001423955; Orlistat - Bio-X trade mark; BIDD:GT0853; ORLISTAT [ORANGE BOOK]; GTPL5277; orb1223504; orb1310386; ORLISTAT [USP MONOGRAPH]; BDBM24567; HY-B0218R; AHLBNYSZXLDEJQ-FWEHEUNISA-N; Tetrahydrolipstatin;Ro-18-0647; GLXC-05010; HMS2051I08; HMS3413P06; HMS3677P06; (S)-((S)-1-((2S,3S)-3-hexyl-4-oxooxetan-2-yl)tridecan-2-yl) 2-formamido-4-methylpentanoate; HY-B0218; MSK10348; THL; Tox21_111437; EBC-11225; HB4009; s1629; AKOS015894875; Tox21_111437_1; CCG-100851; DB01083; FO26582; NC00101; NSC 758881; Ro18-0647; NCGC00165856-01; NCGC00165856-02; NCGC00165856-03; NCGC00165856-14; NCGC00165856-15; NCGC00165856-18; BO164179; R212; SY078600; CS-0694775; NS00004788; O0381; O6845; SW197481-2; Ro-18-0647-002; D04028; EN300-268136; AB00639987-09; AB00639987_10; F801707; Q424163; SR-01000759417-5; SR-01000759417-7; BRD-K63343048-001-12-2; BRD-K63343048-001-13-0; Z2379810072; Orlistat, United States Pharmacopeia (USP) Reference Standard; Orlistat, Pharmaceutical Secondary Standard; Certified Reference Material; N-formyl-L-leucine (1S)-10[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester; N-formyl-L-leucine (S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester; N-formyl-L-leucine-(S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]-dodecyl ester; (2S)-2-formamido-4-methylpentanoic acid [(2S)-1-[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]tridecan-2-yl] ester; (S)-2-FORMYLAMINO-4-METHYL-PENTANOICACID(S)-1-[[(2S,3S)-3-HEXYL-4-OXO-2-OXETANYL]METHYL]-DODECYLESTER; [(2S)-1-[(2R,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl] (2R)-2-formamido-4-methylpentanoate; 104872-04-0; L-LEUCINE, N-FORMYL-, 1-((3-HEXYL-4-OXO-2-OXETANYL)METHYL)DODECYL ESTER, (2S-(2.ALPHA.(R*),3.BETA.))-別名
Orlistatを含む製品
제로원정60밀리그램(오르리스타트)라이트슬림정60밀리그램(오르리스타트)제로비정60밀리그램(오르리스타트)올리원정60밀리그램(오르리스타트)올리스탯정60밀리그램(오르리스타트)제로팻정60밀리그램(오르리스타트)올리원정120밀리그램(오르리스타트)제로비정120밀리그램(오르리스타트)제로원정120밀리그램(오르리스타트)라이트슬림정120밀리그램(오르리스타트)올리스탯정120밀리그램(오르리스타트)제로팻정120밀리그램(오르리스타트)
1/13ページ
Orlistatを販売する企業
한미
한미약품(주)Republic of Korea(주
(주)휴온스Republic of Korea1/8ページ